drugset / Trial / NCT03266939
Rebalancing the Serotonergic System in Cocaine Dependence
RandomizedCrossoverSingle-blindBasic science
Summary
In the United States, 1.5 million people abuse cocaine leading to a host of negative health and economic consequences, yet no FDA approved treatment exists. To develop effective treatments, the following must be considered: 1) do potential medications ameliorate brain disruptions associated with cocaine use? 2) are multiple, targeted treatments necessary? To meet these goals, innovative multi-modal neuroimaging will be used to determine whether rebalancing the serotonergic (5-HT) system reduces cocaine cue reactivity, impulsivity, and normalizes related neurochemistry and brain connectivity.
Timeline
- Start
- 2018-10-04
- Primary completion
- 2018-10-04
- Completion
- 2018-10-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Lorcaserin | Small molecule | 10 mg | — |